Resource Documents
Economic evaluation of investigator-initiated clinical trials conducted by networks – Appendix: Individual trial-level results
Latest Resource
-
Official Opening of the 2020 ACTA Summit: Minister’s Address
-
Statistical Analysis Plan
-
Improving impact of clinical trials through implementability
-
ACTA Board Charter
-
ACTA Constitution
-
ACTA Trial of the Year Award 2020 guidelines and nomination forms
-
Implementability Super Webinar slide deck
-
Implementability Super Webinar
-
Guidance on Implementability
-
ACTA Year in Review: Financial Year 2018/2019
-
Approaches to implementability, implementation and impact of clinical trials: a survey of Australian clinical trials networks and coordinating centres
-
ACTA Resources Brochure
-
ACTA activity work plan 2019 – 2020
-
Report on the activities and achievements of clinical trials networks in Australia 2004 – 2014
-
ANZCA CTN: Impact and Implementation
-
Optimising for Implementation: IMPACT
-
What clinical trialists should know about healthcare policy
-
Implementation of evidence by the ANZICS Clinical Trials Group
-
ALLG Clinical Trials Impact and Implementation
-
Implementation: Clinical Trials
-
What a trialist should know about implementation to practice
-
Cochrane’s approach to implementation
-
The role of AHRTCs in optimising implementation of evidence into practice and policy
-
Submission to MRFF Consultation
-
Submission to Medical Research Future Fund Priority Consultation
-
Medical Research Future Fund – clinical trial funding set to deliver significant benefits to Australian patients and the economy
-
ACTA Advisory Council minutes July 2017
-
Economic evaluation of investigator-initiated clinical trials conducted by networks
-
Open letter to the Hon Greg Hunt MP following announcement of MRFF funding for ACTA and clinical trials
-
Strategies for supporting more trials of high value
-
How can clinical trials networks drive better translation of evidence into better quality care?
-
The Global Perspective: Measuring the impact of Australian-led trials & registries internationally
-
The Clinician Researcher’s Perspective: Measuring impact on individual clinical practice
-
What we don’t know about the health and economic benefit of trials and registries in Australia
-
What we know about the health and economic benefit of trials and registries in Australia
-
Health system sustainability and continuous self-improvement